Literature DB >> 9482143

Left ventricular dysfunction in human immunodeficiency virus (HIV)-infected patients.

J S Cardoso1, B Moura, L Martins, A Mota-Miranda, F Rocha Gonçalves, H Lecour.   

Abstract

We evaluated left ventricular function by echocardiography in a prospective study that included 98 consecutive human immunodeficiency virus (HIV)-infected patients and 40 HIV-seronegative normal controls. When compared with controls, HIV patients showed increased isovolumic relaxation time (101+/-18 ms versus 71+/-10 ms; p<0.0001) and left ventricular diastolic diameters (51+/-6 mm versus 47+/-3 mm; p<0.0005), and decreased fractional shortening (31+/-6% versus 37+/-2%; p<0.0001). Diastolic dysfunction was the most frequent finding (63% of the patients). We found depressed ejection fraction in 31 (32%) patients. Only 8 (8%) patients had symptomatic congestive heart failure. Left ventricular dysfunction was not attributable to intravenous drug abuse or to therapy. It was less severe in earlier stages of the infection (fractional shortening: acquired immunodeficiency syndrome=30%+/-6%, asymptomatic HIV-seropositives 34%+/-5%; p<0.005) and in HIV-2-infected patients. Patients with opportunistic infections (all aetiologies mixed) had more frequent congestive heart failure than those without infections (16% of the patients with versus 4% of the patients without infections; p<0.05). The fact that even asymptomatic HIV-seropositives had signs of left ventricular dysfunction (fractional shortening: asymptomatic HIV-seropositives=34%+/-5%; controls=37%+/-2%; p<0.05) favours the hypothesis of the HIV being one of the causes of these abnormalities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482143     DOI: 10.1016/s0167-5273(97)00276-3

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

Review 1.  Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research.

Authors:  Joshua Remick; Vasiliki Georgiopoulou; Catherine Marti; Igho Ofotokun; Andreas Kalogeropoulos; William Lewis; Javed Butler
Journal:  Circulation       Date:  2014-04-29       Impact factor: 29.690

2.  Relationships among HIV infection, metabolic risk factors, and left ventricular structure and function.

Authors:  William Todd Cade; Edgar Turner Overton; Kristin Mondy; Lisa de las Fuentes; Victor G Davila-Roman; Alan D Waggoner; Dominic N Reeds; Sherry Lassa-Claxton; Melissa J Krauss; Linda R Peterson; Kevin E Yarasheski
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-06       Impact factor: 2.205

3.  Non-ST Elevation Myocardial Infarction and Severe Peripheral Artery Disease in a 20-Year-Old with Perinatally Acquired Human Immunodeficiency Virus Infection.

Authors:  Purva Sharma; Mohamad Kabach; Samineh Sehatbakhsh; Rashida Tharpe; Shaun Isaac; Robert Chait; Kleper De Almeida
Journal:  Case Rep Infect Dis       Date:  2018-04-01

4.  Echocardiographic findings and associated factors in HIV-infected patients at a tertiary hospital in Ethiopia.

Authors:  Esubalew Woldeyes; Henok Fisseha; Hailu Abera Mulatu; Abiy Ephrem; Henok Benti; Mehari Wale Alem; Ahmed Ibrahim Ahmed
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

5.  Echocardiographic patterns in treatment-naïve HIV-positive patients in Lagos, south-west Nigeria.

Authors:  D A Olusegun-Joseph; J N A Ajuluchukwu; C C Okany; A C Mbakwem; D A Oke; N U Okubadejo
Journal:  Cardiovasc J Afr       Date:  2012-07-30       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.